Abstract
Background:
In embryonic myocytes, closure of the mitochondrial permeability transition pore (PTP) drives mitochondrial maturation and cardiac myocyte differentiation. Since neonatal cardiac myocytes remain relatively immature, we hypothesized that inducing PTP closure at this age, by inhibiting the PTP regulator, cyclophilin D (CyPD), genetically or with Cyclosporin A (CsA) and NIM811, would increase cardiac function by increasing mitochondrial maturation and myocyte differentiation.
Methods:
Cultured neonatal myocytes or neonatal mice were treated for 5 d with vehicle, CsA or NIM811. Mitochondrial function and structure were measured in vitro. Myocyte differentiation was assessed by immunolabeling for contractile proteins. Cardiac function was determined using echocardiography.
Results:
The probability of PTP opening was high in WT neonatal myocytes. Treatment with CsA or NIM811 in vitro increased mitochondrial structural complexity and membrane potential, decreased reactive oxygen species levels, and increased myocyte differentiation. WT mice treated with either CsA or NIM811 in vivo for the first 5 d of life had higher ejection fractions. Deleting CyPD had similar effects as CsA and NIM811 on all parameters.
Conclusions:
It may be feasible to inhibit the PTP using available drugs to increase mitochondrial maturation, myocyte differentiation, and cardiac function in neonates.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Hsu DT, Pearson GD. Heart failure in children: part I: history, etiology, and pathophysiology. Circ Heart Fail 2009;2:63–70.
Hsu DT, Pearson GD. Heart failure in children: part II: diagnosis, treatment, and future directions. Circ Heart Fail 2009;2:490–8.
Sole MJ, Jeejeebhoy KN. Conditioned nutritional requirements: therapeutic relevance to heart failure. Herz 2002;27:174–8.
Hom JR, Quintanilla RA, Hoffman DL, et al. The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev Cell 2011;21:469–78.
Beutner G, Eliseev RA, Porter GA Jr . Initiation of electron transport chain activity in the embryonic heart coincides with the activation of mitochondrial complex 1 and the formation of supercomplexes. PLoS One 2014;9:e113330.
Baker CN, Ebert SN. Development of aerobic metabolism in utero: requirement for mitochondrial function during embryonic and fetal periods. OA Biotechnology 2013;2:16.
Porter GA Jr, Hom J, Hoffman D, Quintanilla R, de Mesy Bentley K, Sheu SS. Bioenergetics, mitochondria, and cardiac myocyte differentiation. Prog Pediatr Cardiol 2011;31:75–81.
Gong G, Song M, Csordas G, Kelly DP, Matkovich SJ, Dorn GW 2nd . Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science 2015;350:aad2459.
Zaruba MM, Soonpaa M, Reuter S, Field LJ. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation 2010;121:1992–2000.
Porrello ER, Mahmoud AI, Simpson E, et al. Transient regenerative potential of the neonatal mouse heart. Science 2011;331:1078–80.
Puente BN, Kimura W, Muralidhar SA, et al. The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 2014;157:565–79.
Martin OJ, Lai L, Soundarapandian MM, et al. A role for peroxisome proliferator-activated receptor γ coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth. Circ Res 2014;114:626–36.
Gundemir S, Colak G, Feola J, Blouin R, Johnson GV. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization. Biochim Biophys Acta 2013;1833:1–10.
Argaud L, Loufouat J, Gateau-Roesch O, Gomez L, Robert D, Ovize M. Persistent inhibition of mitochondrial permeability transition by preconditioning during the first hours of reperfusion. Shock 2008;30:552–6.
Petronilli V, Miotto G, Canton M, et al. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 1999;76:725–34.
Folmes CD, Dzeja PP, Nelson TJ, Terzic A. Mitochondria in control of cell fate. Circ Res 2012;110:526–9.
Szabo I, Zoratti M. Mitochondrial channels: ion fluxes and more. Physiol Rev 2014;94:519–608.
Waldmeier PC, Feldtrauer JJ, Qian T, Lemasters JJ. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol Pharmacol 2002;62:22–9.
Argaud L, Gateau-Roesch O, Muntean D, et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005;38:367–74.
Cung TT, Morel O, Cayla G, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med 2015;373:1021–31.
Pawlotsky JM, Flisiak R, Sarin SK, et al.; VITAL-1 study team. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection. Hepatology 2015;62:1013–23.
Elrod JW, Wong R, Mishra S, et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Invest 2010;120:3680–7.
Wang W, Fang H, Groom L, et al. Superoxide flashes in single mitochondria. Cell 2008;134:279–90.
Sokolova N, Pan S, Provazza S, et al. ADP protects cardiac mitochondria under severe oxidative stress. PLoS One 2013;8:e83214.
Alavian KN, Beutner G, Lazrove E, et al. An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci USA 2014;111:10580–5.
Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L. Mitochondrial permeability transition: new findings and persisting uncertainties. Trends Cell Biol 2016;26:655–67.
Mnatsakanyan N, Beutner G, Porter GA, Alavian KN, Jonas EA. Physiological roles of the mitochondrial permeability transition pore. J Bioenerg Biomembr 2017;49:13–25.
Simon MC, Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 2008;9:285–96.
Buggisch M, Ateghang B, Ruhe C, et al. Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase. J Cell Sci 2007;120(Pt 5):885–94.
Schmelter M, Ateghang B, Helmig S, Wartenberg M, Sauer H. Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation. FASEB J 2006;20:1182–4.
Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012;148:399–408.
Lenaz G, Tioli G, Falasca AI, Genova ML. Complex I function in mitochondrial supercomplexes. Biochim Biophys Acta 2016;1857:991–1000.
Acknowledgements
We thank Gisela Beutner, Paul Brookes, Michael O’Reilly, Yves Wang and Dr. Lingan’s Scholarly Oversight Committee for helpful discussions, Julianne Feola and Gail Johnson for help with live/dead cell assays, and Novartis for providing NIM811.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Figures
(DOCX 1586 kb)
Supplementary Table
(DOCX 34 kb)
Rights and permissions
About this article
Cite this article
Lingan, J., Alanzalon, R. & Porter, G. Preventing permeability transition pore opening increases mitochondrial maturation, myocyte differentiation and cardiac function in the neonatal mouse heart. Pediatr Res 81, 932–941 (2017). https://doi.org/10.1038/pr.2017.19
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pr.2017.19
This article is cited by
-
Mitochondrial permeability transition dictates mitochondrial maturation upon switch in cellular identity of hematopoietic precursors
Communications Biology (2024)
-
Molecular mechanisms and consequences of mitochondrial permeability transition
Nature Reviews Molecular Cell Biology (2022)
-
Propofol toxicity in the developing mouse heart mitochondria
Pediatric Research (2022)
-
The newborn Fmr1 knockout mouse: a novel model of excess ubiquinone and closed mitochondrial permeability transition pore in the developing heart
Pediatric Research (2021)
